Structural Basis for the Barrier Abnormality Following Inhibition of HMG CoA Reductase in Murine Epidermis
- 1 February 1992
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 98 (2) , 209-219
- https://doi.org/10.1111/1523-1747.ep12555880
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Lovastatin-Treated Rodent: A New Model of Barrier Disruption and Epidermal HyperplasiaJournal of Investigative Dermatology, 1991
- Ichthyosis, Mental Retardation, and Asymptomatic SpasticityArchives of Dermatology, 1990
- Cholesterol synthesis is required for cutaneous barrier function in mice.Journal of Clinical Investigation, 1990
- Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.Journal of Clinical Investigation, 1990
- Presence of Intact Intercellular Lipid Lamellae in the Upper Layers of the Stratum CorneumJournal of Investigative Dermatology, 1987
- Effect of Essential Fatty Acid Deficiency on Cutaneous Sterol SynthesisJournal of Investigative Dermatology, 1986
- Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O.Journal of Histochemistry & Cytochemistry, 1985
- Neutral Lipid Storage Disease With IchthyosisArchives of Dermatology, 1985
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- The Regeneration Rate of the Water Vapour Loss of Heavily Damaged SkinDermatology, 1965